Table 4.
Laboratory parameters among study participants at 48 weeks
| Parameter | Treatment (n = 26) | Control (n = 22) | p-value |
|---|---|---|---|
| White blood cell (/µL) | 7,910 ± 1,580 | 6,980 ± 1,050 | 0.06 |
| Neutrophils (%) | 60.9 ± 8.9 | 56.3 ± 7.2 | 0.13 |
| Absolute neutrophil count | 4,840 ± 1,340 | 3,930 ± 750 | 0.08 |
| Lymphocytes (%) | 30.0 ± 8.0 | 33.2 ± 7.0 | 0.25 |
| Monocytes (%) | 7.6 ± 2.4 | 6.1 ± 1.4 | 0.04 |
| Eosinophils (%) | 1.1 ± 0.5 | 3.8 ± 2.8 | <0.001 |
| Basophils (%) | 0.4 ± 0.2 | 0.7 ± 0.3 | 0.02 |
| Hemoglobin (g/dL) | 13.4 ± 2.1 | 12.9 ± 2.1 | 0.53 |
| Platelets (109/L) | 245 ± 35 | 254 ± 54 | 0.56 |
| Blood urea nitrogen (mg/dL) | 28.5 ± 11.8 | 35.1 ± 13.7 | 0.09 |
| Total protein (g/dL) | 6.5 ± 0.5 | 6.8 ± 0.6 | 0.10 |
| Albumin (g/dL) | 4.1 ± 0.3 | 4.0 ± 0.3 | 0.27 |
| Glucose (mg/dL) | 98.4 ± 12.3 | 107.0 ± 23.4 | 0.22 |
| Sodium (mEq/L) | 141 ± 2 | 140 ± 3 | 0.59 |
| Potassium (mEq/L) | 4.4 ± 0.4 | 4.9 ± 0.2 | <0.001 |
| Chloride (mEq/L) | 105.9 ± 2.5 | 107.7 ± 2.6 | 0.11 |
Data are expressed as mean ± standard deviation.